The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Nov. 08, 2006
Young-gil Ahn, Seongnam-si, KR;
Jong Woo Kim, Suwon-si, KR;
Keuk Chan Bang, Incheon, KR;
Bum Woo Park, Gwangmyeong-si, KR;
SE Young Kim, Seongnam-si, KR;
Kyungik Lee, Anyang-si, KR;
Kyuhang Lee, Yongin-si, KR;
Myoung-sil Ko, Seoul, KR;
Han Kyong Kim, Yongin-si, KR;
Young Hoon Kim, Seoul, KR;
Maeng Sup Kim, Seoul, KR;
Gwan Sun Lee, Seoul, KR;
Young-Gil Ahn, Seongnam-si, KR;
Jong Woo Kim, Suwon-si, KR;
Keuk Chan Bang, Incheon, KR;
Bum Woo Park, Gwangmyeong-si, KR;
Se Young Kim, Seongnam-si, KR;
Kyungik Lee, Anyang-si, KR;
Kyuhang Lee, Yongin-si, KR;
Myoung-Sil Ko, Seoul, KR;
Han Kyong Kim, Yongin-si, KR;
Young Hoon Kim, Seoul, KR;
Maeng Sup Kim, Seoul, KR;
Gwan Sun Lee, Seoul, KR;
Hanmi Pharm. Co., Ltd., , KR;
Abstract
The present invention relates to a novel quinazoline derivative compound having the formula (1) as follows: with the constituents defined in claim, and a pharmaceutically acceptable salt thereof as a multiplex inhibitor, a method for the preparation thereof, and a pharmaceutical composition and a therapeutic composition comprising same as an active ingredient. The inventive quinazoline derivative as a multiplex inhibitor can selectively and effectively inhibit diseases caused by the overactivity of a tyrosine kinase.